Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
2.
Sante Publique ; 28(5): 633-640, 2016 Nov 25.
Artigo em Francês | MEDLINE | ID: mdl-28155739

RESUMO

Objective: Laboratory tests play an important role in general practice. Access to a clinical laboratory is essential and can potentially influence whether or not these tests are performed. This study assessed the impact of the distance between the patient's home and the clinical pathology laboratory on laboratory monitoring of diabetes. Methods: This was a retrospective observational study conducted over a period of 3 years on a cohort of diabetic patients from 11 clinical pathology laboratories in the Saint-Etienne region. The primary endpoint was at least three HbA1c, one serum creatinine, one lipid profile and one microalbuminuria over a 12-month period. Statistical analysis was based on the following variables: distance between the patient's home and the clinical pathology laboratory, patient's age, their health insurance, type of urban area and the site of blood sampling. Results: Among the 12,773 subjects included, 1,889 (14.8%) complied with the monitoring procedure. The successful monitoring rate decreased by 38% when the distance from the laboratory was more than 5 km (OR 1.38 [1.18 to 1.61]). Monitoring compliance increased with age (OR 0.71 [0.61 to 0.83] for subjects 55-65 years old and 0.61 [0.53 to 0.71] for subjects over 65 years old). However, patients in rural areas and in urban areas with less than 10,000 inhabitants presented better compliance with monitoring than patients living in towns with more than 200,000 inhabitants. Conclusions: Compliance with laboratory monitoring decreased as the distance between the patient's home and the clinical pathology laboratory increased. These results raise the question of the possible role of home sampling and the availability of other relevant tests required for general practice.


Assuntos
Diabetes Mellitus Tipo 2/terapia , Acessibilidade aos Serviços de Saúde , Laboratórios , Monitorização Fisiológica , Cooperação do Paciente , Idoso , Feminino , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Disparidades em Assistência à Saúde/estatística & dados numéricos , Humanos , Laboratórios/organização & administração , Masculino , Pessoa de Meia-Idade , Monitorização Fisiológica/métodos , Cooperação do Paciente/estatística & dados numéricos , Estudos Retrospectivos
3.
Med Oncol ; 31(12): 322, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25416045

RESUMO

The aim of the study was to analyze the medical and economic interest of OSNA molecular technique, compared to conventional postoperative histopathologic evaluation for sentinel lymph node exploration in breast cancer patients. This retrospective cost-benefit study was conducted in the French Universitary Hospital of Saint Etienne on patients who received sentinel lymph node exploration between July 1, 2007 and December 31, 2009. Lymph nodes were analyzed by conventional postoperative histological evaluation in group 1 (82 patients) and OSNA in group 2 (86 patients). Costs were analyzed in three different ways: surgery cost, hospitalization cost and histopathologic cost. Average operating time was slightly shorter for group 1 (histology) [71.9 vs. 76.8 min for group 2 (OSNA)]. Time and operating costs were not significantly different (p = 0.293). The average cost of pathological examination was significantly higher in group 2 (35.04 euros per node in group 1 vs. 291.84 euros per node in group 2 p < 10(-3)). The average length of hospital stay was significantly longer in group 1 (5.4 days in group 1 vs. 4.2 days in group 2, p = 0.0065). The total costs were not significantly different between both groups (3,774.6 euros in group 1 vs. 3,393.9 euros in group 2 p = 0.055). The sentinel lymph node analysis with OSNA technique does not lead to higher expenses. It also avoids another surgery for 20% of patients. A prospective multicentric medico-economic study made with a larger effective would probably confirm these results.


Assuntos
Neoplasias da Mama/cirurgia , Técnicas de Amplificação de Ácido Nucleico/métodos , Biópsia de Linfonodo Sentinela/economia , Biópsia de Linfonodo Sentinela/métodos , Neoplasias da Mama/patologia , Análise Custo-Benefício , Feminino , França , Humanos , Cuidados Intraoperatórios , Tempo de Internação/economia , Metástase Linfática/diagnóstico , Metástase Linfática/patologia , Pessoa de Meia-Idade , Técnicas de Amplificação de Ácido Nucleico/economia , Cuidados Pós-Operatórios , Estudos Retrospectivos , Fatores de Tempo
4.
AMIA Annu Symp Proc ; 2010: 61-5, 2010 Nov 13.
Artigo em Inglês | MEDLINE | ID: mdl-21346941

RESUMO

In France, clinical procedures are coded with the French procedures classification (Classification Commune des Actes Médicaux, CCAM) and recorded in every hospital. CCAM uses hierarchical semi-structured codes which describe procedures (topography, action, access mode and/or technique). This amount of information could be analyzed and used for clinical and medico-economic evaluation. But relevant and practical data searches are difficult. In this paper we present a use case about searching for endoscopic activities in a case mix database to evaluate the relevance of the hierarchical organization and semi structured codes of CCAM in order to retrieve data already coded using this controlled vocabulary. Precision was 0.79 and recall 0.84 in the hierarchical search whereas precision was 0.94 and recall was 0.81 using part of the code related to access mode and/or technique. We discuss a revision of the CCAM by the use of an existing modeling (from the GALEN project) and better knowledge representation for each procedure.


Assuntos
Hospitais , Vocabulário Controlado , Grupos Diagnósticos Relacionados , França , Humanos , Armazenamento e Recuperação da Informação , Terminologia como Assunto
5.
J Clin Epidemiol ; 62(6): 660-6, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19070463

RESUMO

OBJECTIVE: To estimate breast cancer incidence in the general population using a method that corrects for lack of sensitivity and specificity in the identification of incident breast cancer in inpatient claims data. STUDY DESIGN AND SETTINGS: Two-phase study: phase 1 to identify incident cases in claims data, and phase 2 to estimate sensitivity and specificity in a subset of the population. Two algorithms (1: principal diagnosis; 2: principal diagnosis+specific surgery procedures) were used to identify incident cases in claims of women aged 20 years or older, living in a French district covered by a cancer registry. Sensitivity and specificity were estimated in one district and used to correct incident cases identified. RESULTS: The sensitivity and specificity for algorithms 1 and 2 were 69.0% and 99.89%, and 64.4% and 99.93%, respectively. In contrast to specificity, the sensitivity for both algorithms was lower for women younger than 40 years and older than 65 years. Cases reported by cancer registries were closer to cases identified with algorithm 2 (-3.2% to +20.1%) and to corrected numbers with algorithm 1 (-1% to +15%). CONCLUSION: To obtain reliable estimates of breast cancer incidence in the general population, sensitivity and specificity, which reflect medical and coding practice variations, are necessary.


Assuntos
Algoritmos , Neoplasias da Mama/epidemiologia , Revisão da Utilização de Seguros , Adulto , Idoso , Neoplasias da Mama/diagnóstico , Bases de Dados Factuais , Feminino , França/epidemiologia , Humanos , Incidência , Pessoa de Meia-Idade , Sistema de Registros , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA